Oxford Asset Management »

Entrada Therapeutics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $169k 29k 5.80